Although we have demonstrated in our transgenic mouse models that Nanos3 is potentially oncogenic in NSCLC, our in vivo data do not support the previously proposed role of Nanos3 in E-cadherin suppression and EMT induction in lung cancer [27]. Here, CDH1 is linked to non-small cell lung carcinoma.